Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes

Details for Australian Patent Application No. 2002300507 (hide)

Owner The Regents of the University of California Collateral Therapeutics, Inc.

Inventors Hammond, H.Kirk; Kelly, Tamsin L.

Agent FB Rice

Pub. Number AU-B-2002300507

Parent 71735

Filing date 9 August 2002

Wipo publication date 13 February 2003

Acceptance publication date 23 March 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300507

13 March 2003 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee to Collateral Therapeutics, Inc. and The Regents of the University of California.

23 March 2006 Application Accepted

  Published as AU-B-2002300507

20 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300508-Information display system

2002300506-Resistance marker for monocotyledons